Liver cell therapy and tissue engineering for transplantation

Seminars in Pediatric Surgery

Volumn 23, Issue 3, 2014, Pages 150-155

  Vacanti, Joseph P ^a,b,c   Kulig, Katherine M ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hepatocytes; Liver transplantation alternatives; Organ engineering; Regenerative medicine; Stem cells; Tissue engineering; Xenotransplantation

Indexed keywords

ARTICLE; BIOARTIFICIAL LIVER; GENETIC DISORDER; HEPATOCYTE TRANSPLANTATION; HUMAN; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER REGENERATION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; TISSUE ENGINEERING; ARTIFICIAL LIVER; BIOLOGICAL THERAPY; EMBRYONIC STEM CELL; END STAGE LIVER DISEASE; LIVER TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; PLURIPOTENT STEM CELL; PROCEDURES; TISSUE REGENERATION; TISSUE SCAFFOLD; TRANSPLANTATION;

CELL- AND TISSUE-BASED THERAPY; EMBRYONIC STEM CELLS; END STAGE LIVER DISEASE; GUIDED TISSUE REGENERATION; HEPATOCYTES; HUMANS; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; MESENCHYMAL STEM CELL TRANSPLANTATION; PLURIPOTENT STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84903484029     PISSN: 10558586     EISSN: 15329453     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2014.05.001     Document Type: Article

References (62)

1. UNOS. Annual report of the U.S. organ procurement and transplantation network and the scientific registry of transplant recipients: transplant data 1994-2014. Department of Health and Human Services. Health Resources and Services Administration. Healthcare Systems Bureau. Division of Transplantation. Rockville, MD; 2014.
2. Ryckman F.C., Bucuvalas J.C., Nathan J., et al. Outcomes following liver transplantation. Semin Pediatr Surg 2008, 17(2):123-130.
3. Krebs N., Neville C., Vacanti J.P. Cellular transplants for liver diseases. Cellular Transplantation: From Laboratory to Clinic 2011, 215-240. Academic Press, Burlington, MA. C. Halberstadt, D.F. Emerich (Eds.).
4. Bohm F., Kohler U.A., Speicher T., Werner S. Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2010, 2(8):294-305.
5. Gridelli B., Vizzini G., Pietrosi G., et al. Efficient human fetal liver cell isolation protocol based on vascular perfusion for liver cell-based therapy and case report on cell transplantation. Liver Transpl 2012, 18(2):226-237.
6. Carpentier B., Gautier A., Legallais C. Artificial and bioartificial liver devices: present and future. Gut 2009, 58(12):1690-1702.
7. Kuddus R., Patzer J.F., Lopez R., et al. Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. Transplantation 2002, 73(3):420-429.
8. Wang H.H., Wang Y.J., Liu H.L., et al. Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system. World J Gastroenterol 2006, 12(8):1287-1291.
9. Sachs D.H., Sykes M., Yamada K. Achieving tolerance in pig-to-primate xenotransplantation: reality or fantasy. Transpl Immunol 2009, 21(2):101-105.
10. Rebulla P., Lecchi L. Towards responsible cord blood banking models. Cell Prolif 2011, 44(suppl 1):30-34.
11. Armson B.A. Umbilical cord blood banking: implications for perinatal care providers. J Obstet Gynaecol Can 2005, 27(3):263-290.
12. Fujii H., Hirose T., Oe S., et al. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol 2002, 36(5):653-659.
13. Kienstra K.A., Jackson K.A., Hirschi K.K. Injury mechanism dictates contribution of bone marrow-derived cells to murine hepatic vascular regeneration. Pediatr Res 2008, 63(2):131-136.
14. Wang J., Clark J.B., Rhee G.S., et al. Proliferation and hepatic differentiation of adult-derived progenitor cells. Cells Tissues Organs 2003, 173(4):193-203.
15. Semeraro R., Carpino G., Cardinale V., et al. Multipotent stem/progenitor cells in the human foetal biliary tree. J Hepatol 2012, 57(5):987-994.
16. Sun J., Wang L., Waring M.A., et al. Simple and reliable methods to assess hepatocyte viability in bioartificial liver support system matrices. Artif Organs 1997, 21(5):408-413.
17. Nyberg S.L., Mann H.J., Remmel R.P., Hu W.S., Cerra F.B. Pharmacokinetic analysis verifies P450 function during in vitro and in vivo application of a bioartificial liver. ASAIO J 1993, 39(3):M252-M256.
18. Greenhough S., Bradburn H., Gardner J., Hay D.C. Development of an embryoid body-based screening strategy for assessing the hepatocyte differentiation potential of human embryonic stem cells following single-cell dissociation. Cell Reprogram 2013, 15(1):9-14.
19. Funakoshi N., Duret C., Pascussi J.M., et al. Comparison of hepatic-like cell production from human embryonic stem cells and adult liver progenitor cells: CAR transduction activates a battery of detoxification genes. Stem Cell Rev 2011, 7(3):518-531.
20. Yamada T., Yoshikawa M., Kanda S., et al. In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 2002, 20(2):146-154.
21. Jones E.A., Tosh D., Wilson D.I., Lindsay S., Forrester L.M. Hepatic differentiation of murine embryonic stem cells. Exp Cell Res 2002, 272(1):15-22.
22. Choi D., Oh H.J., Chang U.J., et al. In vivo differentiation of mouse embryonic stem cells into hepatocytes. Cell Transplant 2002, 11(4):359-368.
23. Miyashita H., Suzuki A., Fukao K., Nakauchi H., Taniguchi H. Evidence for hepatocyte differentiation from embryonic stem cells in vitro. Cell Transplant 2002, 11(5):429-434.
24. Kazemnejad S., Allameh A., Gharehbaghian A., et al. Efficient replacing of fetal bovine serum with human platelet releasate during propagation and differentiation of human bone-marrow-derived mesenchymal stem cells to functional hepatocyte-like cells. Vox Sang 2008, 95(2):149-158.
25. Soto-Gutierrez A., Kobayashi N., Rivas-Carrillo J.D., et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 2006, 24(11):1412-1419.
26. Cai X., Lin Y., Friedrich C.C., et al. Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev 2009, 5(4):437-445.
27. Ishkitiev N., Yaegaki K., Imai T., et al. High-purity hepatic lineage differentiated from dental pulp stem cells in serum-free medium. J Endod 2012, 38(4):475-480.
28. Ikeda E., Yagi K., Kojima M., et al. Multipotent cells from the human third molar: feasibility of cell-based therapy for liver disease. Differentiation 2008, 76(5):495-505.
29. Campard D., Lysy P.A., Najimi M., Sokal E.M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008, 134(3):833-848.
30. Di Campli C., Piscaglia A.C., Pierelli L., et al. A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. Dig Liv Dis 2004, 36(9):603-613.
31. Kakinuma S., Tanaka Y., Chinzei R., et al. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 2003, 21(2):217-227.
32. Sensken S., Waclawczyk S., Knaupp A.S., et al. In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy 2007, 9(4):362-378.
33. Zhang Y.N., Lie P.C., Wei X. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells. Cytotherapy 2009, 11(5):548-558.
34. Lysy P.A., Campard D., Smets F., et al. Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells. Cell Prolif 2008, 41(1):36-58.
35. Seo M.J., Suh S.Y., Bae Y.C., Jung J.S. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005, 328(1):258-264.
36. Meier R.P., Muller Y.D., Morel P., Gonelle-Gispert C., Buhler L.H. Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?. Stem Cell Res 2013, 11(3):1348-1364.
37. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
38. Muller L.U., Daley G.Q., Williams D.A. Upping the ante: recent advances in direct reprogramming. Mol Ther 2009, 17(6):947-953.
39. Hou P., Li Y., Zhang X., et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341(6146):651-654.
40. Obokata H., Wakayama T., Sasai Y., et al. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature 2014, 505(7485):641-647.
41. Takebe T., Sekine K., Enomura M., et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013, 499(7459):481-484.
42. Mullon C., Pitkin Z. The HepatAssist bioartificial liver support system: clinical study and pig hepatocyte process. Expert Opin Investig Drugs 1999, 8(3):229-235.
43. Custer L., Mullon C.J. Oxygen delivery to and use by primary porcine hepatocytes in the HepatAssist 2000 system for extracorporeal treatment of patients in end-stage liver failure. Adv Exp Med Biol 1998, 454:261-271.
44. Demetriou A.A., Brown R.S., Busuttil R.W., et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004, 239(5):660-667. [discussion 667-670].
45. Ellis A.J., Hughes R.D., Wendon J.A., et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996, 24(6):1446-1451.
46. Carraro A., Hsu W.M., Kulig K.M., et al. In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed Microdevices 2008, 10(6):795-805.
47. Hsu W.M., Carraro A., Kulig K.M., et al. Liver-assist device with a microfluidics-based vascular bed in an animal model. Ann Surg 2010, 252(2):351-357.
48. Ding J., Yannam G.R., Roy-Chowdhury N., et al. Spontaneous hepatic repopulation in transgenic mice expressing mutant human alpha1-antitrypsin by wild-type donor hepatocytes. J Clin Invest 2011, 121(5):1930-1934.
49. Sandgren E.P., Palmiter R.D., Heckel J.L., et al. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991, 66(2):245-256.
50. Azuma H., Paulk N., Ranade A., et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 2007, 25(8):903-910.
51. Dhawan A., Puppi J., Hughes R.D., Mitry R.R. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010, 7(5):288-298.
52. Soltys K.A., Soto-Gutierrez A., Nagaya M., et al. Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol 2010, 53(4):769-774.
53. Esrefoglu M. Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol 2013, 19(40):6757-6773.
54. Puppi J., Strom S.C., Hughes R.D., et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 2012, 21(1):1-10.
55. Kulig K.M., Luo X., Finkelstein E.B., et al. Biologic properties of surgical scaffold materials derived from dermal ECM. Biomaterials 2013, 34(23):5776-5784.
56. Uygun B.E., Soto-Gutierrez A., Yagi H., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010, 16(7):814-820.
57. Zhou P., Lessa N., Estrada D.C., et al. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transpl 2011, 17(4):418-427.
58. Shirakigawa N., Takei T., Ijima H. Base structure consisting of an endothelialized vascular-tree network and hepatocytes for whole liver engineering. J Biosci Bioeng 2013, 116(6):740-745.
59. Yagi H., Fukumitsu K., Fukuda K., et al. Human-scale whole-organ bioengineering for liver transplantation: a regenerative medicine approach. Cell Transplant 2013, 22(2):231-242.
60. Baptista P.M., Siddiqui M.M., Lozier G., et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011, 53(2):604-617.
61. Kehr D.C., Raschzok N., Sauer I.M. A novel cannulation technique for isolation of human hepatocytes from explanted diseased whole livers. Transplant Proc 2012, 44(4):999-1001.
62. Hossein Aghdaie M., Geramizadeh B., Azarpira N., et al. Hepatocyte isolation from unused/rejected livers for transplantation: initial step toward hepatocyte transplantation, the first experience from iran. Hepat Mon 2013, 13(8):e10397.